Publications by authors named "Orla M Fitzpatrick"

Claim this Profile
R
Redefining gastroesophageal junction cancer care with perioperative immunotherapy, minimal residual disease monitoring and new targets.
Orla M Fitzpatrick, Yelena Y Janjigian

Nat Rev Gastroenterol Hepatol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cutaneous Immune-Related Adverse Events and Efficacy of Immune Checkpoint Inhibitors for Patients With Advanced Solid Organ Malignancies.
David O'Reilly, Gregg Murray, Orla M Fitzpatrick, Hebatalla Ismail, Gavin P Dowling

Int J Dermatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant chemoradiation in older Irish adult patients with oesophageal cancer: a retrospective institutional review of clinical outcomes and hematological toxicity.
Ronan Andrew McLaughlin, David McMahon, Christopher Cluxton, Orla Meave Fitzpatrick, Michael Conroy

BMC Cancer· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical benefit and cost of plasma-first next-generation sequencing in patients with newly diagnosed advanced non-small cell lung cancer in Ireland: The PLAN study.
David O'Reilly, Anthony O'Grady, Conor Hayes, Laura Piggott, Ruaidhri Keane, Orla M Fitzpatrick

Eur J Cancer· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case report: Clonal evolution analysis of a rare case of meningioma lung metastases identifies actionable alterations in matched longitudinal tumour samples.
Nicola Cosgrove, Orla M Fitzpatrick, Liam Grogan, Bryan T Hennessy, Simon J Furney

Front Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determinants of gemcitabine response in pancreatic cancer: are we there?
Orla M Fitzpatrick, Grainne M O'Kane

J Gastrointest Oncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Apalutamide-Induced Toxic Epidermal Necrolysis in a Caucasian Patient with Metastatic Castration-Sensitive Prostate Cancer: A Case Report and Review of the Literature.
Calvin R Flynn, Shun-Chieh Liu, Berbie Byrne, James Ralph, Gabriela Paz, Orla M Fitzpatrick

Case Rep Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: The cost of cancer care: how far would you go for a trial?
Orla M Fitzpatrick, Catherine Murphy, Erica Duignan, Keith Egan, Bryan T Hennessy

Ir J Med Sci· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An observational study of dose dense chemotherapy with lipegfilgrastim support in early breast cancer.
Ahmed Rashed, Orla M Fitzpatrick, David J Easty, Zac Coyne, Dearbhaile Collins

BMC Cancer· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The cost of cancer care: how far would you go for a trial?
Orla M Fitzpatrick, Catherine Murphy, Erica Duignan, Keith Egan, Bryan T Hennessy

Ir J Med Sci· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Profile of Trastuzumab Deruxtecan in the Management of Patients with HER2-Positive Unresectable or Metastatic Breast Cancer: An Evidence-Based Review.
Anna S Linehan, Orla M Fitzpatrick, Patrick G Morris

Breast Cancer (Dove Med Press)· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis